Precautions while taking capmatinib

Capmatinib (Capmatinib) is a targeted therapy drug for the treatment of non-small cell lung cancer (NSCLC). Its use requires patients and doctors to cooperate closely and follow a series of medication precautions to ensure the efficacy and safety of the drug. Here are some things to note when using capmatinib:

1.Doctor’s prescription and guidance: Patients should use capmatinib strictly in accordance with the doctor’s prescription and guidance. Doctors will develop a personalized treatment plan based on the patient's specific condition, physical condition and other factors.

2.Dosage and medication time: Capmatinib is usually an oral drug. Patients should take the drug accurately according to the doctor's recommendations and follow the prescribed dosage and medication time. Usually, capmatinib is taken after meals or as directed by your doctor.

3.Regular follow-up and monitoring: During the medication period, patients need to receive regular medical monitoring and follow-up to ensure the efficacy and safety of the drug. This may include blood tests, liver function tests, electrocardiograms, etc.

4.Adverse reaction reporting: Patients should pay close attention to their physical condition during medication and promptly report any discomfort or adverse reactions, such as headache, nausea, vomiting, fatigue, etc., to the doctor. The doctor will adjust the treatment plan based on the feedback.

5.Interactions with other drugs: While taking capmatinib, patients should inform their doctor about all drugs they are taking, including prescription drugs, over-the-counter drugs, and supplements. Some drugs may interact with capmatinib and affect the absorption and metabolism of the drug.

6.Avoid alcohol and certain foods: Patients may need to avoid alcohol while taking capmatinib because alcohol may affect the metabolism and excretion of the drug. In addition, some foods may also affect the absorption of drugs, and patients should follow their doctor's recommendations for diet.

7.Pregnant and breastfeeding women: Capmatinib may cause adverse effects on the fetus and should be avoided by pregnant women. Patients should take effective contraceptive measures during treatment and continue to use contraceptive measures during treatment and for a certain period of time after discontinuation of treatment. Breastfeeding women may need to stop breastfeeding.

8.Driving and operating machinery: Capmatinib may cause adverse reactions such as fatigue and dizziness, so patients need to pay attention to driving and performing mechanical operations that require a high degree of concentration during medication.

9.Drug storage: Capmatinib needs to be stored in a dry, cool place, away from direct sunlight. Patients should store their medications according to the directions on the medication and avoid changing doses or stopping medications on their own.

In general, patients should strictly follow the doctor's recommendations when using capmatinib, maintain close communication with the medical team, and promptly report any discomfort symptoms to ensure the best therapeutic effect of the drug while minimizing potential adverse reactions. Compliance with these medication precautions is critical to the patient's treatment progress.

Capmatinib is not yet available in China, so patients cannot purchase it domestically yet and need to purchase it through overseas channels. Currently, there are Hong Kong version of original drugs and foreign original drugs and generic drugs. The price of Hong Kong version of original drugs is about 35,000 yuan. The overseas original drugs are mainly European version of original drugs, and the price is more than 50,000 yuan, so original drugs are still relatively expensive. Generic drugs on the market abroad are much cheaper, mainly Laos generic drugs, the price is around 3,000 to 4,000 yuan, and the ingredients of original drugs and generic drugs are basically the same.